AIM ImmunoTech Inc (AIM) - Financial and Strategic SWOT Analysis Review

July 2021 | 49 pages | ID: HDDA42B0C29EN
GlobalData

Abstracts

AIM ImmunoTech Inc (AIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

AIM ImmunoTech Inc (AIM ImmunoTech), formerly Hemispherx Biopharma Inc, is an immuno

pharma company. The company focuses on the research and development of therapeutics for the treatment of multiple types of cancers, viruses and immune-deficiency disorders. Its flagship products include Ampligen (rintatolimod) sterile solution which is indicated for the treatment of patients with chronic fatigue syndrome; and Alferon N Injection used for the treatment of refractory or recurrent external condylomata acuminate. The company’s pipeline products are intended to treat various types of cancers, including ovarian, breast, colorectal, renal cell carcinoma, melanoma, pancreatic, bladder cancers, MERS and influenza virus. The company operates production facility in New Brunswick, New Jersey. AIM ImmunoTech is headquartered in Ocala, Florida, the US.

AIM ImmunoTech Inc Key Recent Developments

May 18,2021: AIM ImmunoTech Provides First Quarter 2021 Business Update
Mar 31,2021: AIM ImmunoTech Reports 2020 Year-End Financial Results
Mar 10,2021: AIM ImmunoTech to Participate at M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference
Mar 04,2021: AIM ImmunoTech to Present at the H.C. Wainwright Global Life Sciences Conference on March 9th
Jan 15,2021: AIM ImmunoTech Reschedules Investor Conference Call to January 21, 2021 at 11AM ET

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

AIM ImmunoTech Inc - Key Facts
AIM ImmunoTech Inc - Key Employees
AIM ImmunoTech Inc - Key Employee Biographies
AIM ImmunoTech Inc - Major Products and Services
AIM ImmunoTech Inc - History
AIM ImmunoTech Inc - Company Statement
AIM ImmunoTech Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
AIM ImmunoTech Inc - Business Description
R&D Overview
AIM ImmunoTech Inc - Corporate Strategy
AIM ImmunoTech Inc - SWOT Analysis
SWOT Analysis - Overview
AIM ImmunoTech Inc - Strengths
AIM ImmunoTech Inc - Weaknesses
AIM ImmunoTech Inc - Opportunities
AIM ImmunoTech Inc - Threats
AIM ImmunoTech Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

AIM ImmunoTech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
AIM ImmunoTech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
AIM ImmunoTech Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 18, 2021: AIM ImmunoTech Provides First Quarter 2021 Business Update
Mar 31, 2021: AIM ImmunoTech Reports 2020 Year-End Financial Results
Mar 10, 2021: AIM ImmunoTech to Participate at M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference
Mar 04, 2021: AIM ImmunoTech to Present at the H.C. Wainwright Global Life Sciences Conference on March 9th
Jan 15, 2021: AIM ImmunoTech Reschedules Investor Conference Call to January 21, 2021 at 11AM ET
Jan 11, 2021: AIM ImmunoTech Postpones Investor Conference Call Will Reschedule for a Later Date
Nov 13, 2020: AIM ImmunoTech provides third quarter 2020 business update
Oct 30, 2020: BioFlorida Names AIM ImmunoTech CEO Thomas K. Equels as Entrepreneur of the Year
Aug 17, 2020: AIM ImmunoTech provides second quarter 2020 business update and reports progress in both COVID-19 and cancer trials
Jul 10, 2020: AIM ImmunoTech to study Ampligen in Covid-19 patients with cancer

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

AIM ImmunoTech Inc, Key Facts
AIM ImmunoTech Inc, Key Employees
AIM ImmunoTech Inc, Key Employee Biographies
AIM ImmunoTech Inc, Major Products and Services
AIM ImmunoTech Inc, History
AIM ImmunoTech Inc, Subsidiaries
AIM ImmunoTech Inc, Key Competitors
AIM ImmunoTech Inc, Ratios based on current share price
AIM ImmunoTech Inc, Annual Ratios
AIM ImmunoTech Inc, Annual Ratios (Cont...1)
AIM ImmunoTech Inc, Interim Ratios
AIM ImmunoTech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
AIM ImmunoTech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
AIM ImmunoTech Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

AIM ImmunoTech Inc, Performance Chart (2016 - 2020)
AIM ImmunoTech Inc, Ratio Charts
AIM ImmunoTech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
AIM ImmunoTech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021